Acuta Capital Partners, LLC Iridex Corp Transaction History

Acuta Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.77 - $2.57 $2.07 Million - $3.01 Million	-1,171,300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$4.39 - $5.61 $14,047 - $17,952	-3,200 Reduced 0.27%	1,171,300 $5.33 Million
Q4 2018 Feb 14, 2019	SELL	$3.85 - $6.3 $2.98 Million - $4.87 Million	-773,000 Reduced 39.69%	1,174,500 $5.52 Million
Q3 2018 Nov 07, 2018	SELL	$6.0 - $9.15 $315,000 - $480,375	-52,500 Reduced 2.63%	1,947,500 $12.4 Million
Q3 2017 Nov 14, 2017	BUY	$8.19 - $10.25 $16.4 Million - $20.5 Million	2,000,000	2,000,000 $18.7 Million

3.3M

500

33.5K

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $26.7M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.